Stokes Family Office’s Opus Genetics, Inc. Common Stock IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.4K | Hold |
12,120
| – | – | ﹤0.01% | 234 |
|
|
2025
Q1 | $11.9K | Hold |
12,120
| – | – | ﹤0.01% | 233 |
|
|
2024
Q4 | $14.4K | Hold |
12,120
| – | – | ﹤0.01% | 244 |
|
|
2024
Q3 | $15.9K | Hold |
12,120
| – | – | ﹤0.01% | 227 |
|
|
2024
Q2 | $18.5K | Hold |
12,120
| – | – | ﹤0.01% | 223 |
|
|
2024
Q1 | $24.4K | Hold |
12,120
| – | – | ﹤0.01% | 222 |
|
|
2023
Q4 | $36.5K | Sell |
12,120
-910
| -7% | -$2.74K | ﹤0.01% | 221 |
|
|
2023
Q3 | $43.7K | Buy |
13,030
+780
| +6% | +$2.61K | 0.01% | 338 |
|
|
2023
Q2 | $53.2K | Buy |
12,250
+130
| +1% | +$564 | 0.01% | 327 |
|
|
2023
Q1 | $45.5K | Hold |
12,120
| – | – | 0.01% | 300 |
|
|
2022
Q4 | $42.8K | Hold |
12,120
| – | – | 0.01% | 274 |
|
|
2022
Q3 | $24K | Hold |
12,120
| – | – | ﹤0.01% | 271 |
|
|
2022
Q2 | $23K | Hold |
12,120
| – | – | ﹤0.01% | 271 |
|
|
2022
Q1 | $39K | Hold |
12,120
| – | – | 0.01% | 257 |
|
|
2021
Q4 | $45K | Hold |
12,120
| – | – | 0.01% | 249 |
|
|
2021
Q3 | $62K | Hold |
12,120
| – | – | 0.01% | 226 |
|
|
2021
Q2 | $64K | Hold |
12,120
| – | – | 0.01% | 217 |
|
|
2021
Q1 | $70K | Buy |
+12,120
| New | +$70K | 0.01% | 194 |
|